ISUPREL Drug Patent Profile
✉ Email this page to a colleague
When do Isuprel patents expire, and what generic alternatives are available?
Isuprel is a drug marketed by Sanofi Aventis Us and Bausch and is included in four NDAs.
The generic ingredient in ISUPREL is isoproterenol hydrochloride. There are seventeen drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the isoproterenol hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Isuprel
A generic version of ISUPREL was approved as isoproterenol hydrochloride by NEXUS on August 2nd, 2017.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ISUPREL?
- What are the global sales for ISUPREL?
- What is Average Wholesale Price for ISUPREL?
Summary for ISUPREL
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 4 |
| Raw Ingredient (Bulk) Api Vendors: | 118 |
| Clinical Trials: | 5 |
| Patent Applications: | 954 |
| Drug Prices: | Drug price information for ISUPREL |
| What excipients (inactive ingredients) are in ISUPREL? | ISUPREL excipients list |
| DailyMed Link: | ISUPREL at DailyMed |
Recent Clinical Trials for ISUPREL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Brain & Behavior Research Foundation | N/A |
| University of Oklahoma | N/A |
| Vanderbilt University Medical Center | N/A |
US Patents and Regulatory Information for ISUPREL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sanofi Aventis Us | ISUPREL | isoproterenol hydrochloride | AEROSOL, METERED;INHALATION | 011178-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Sanofi Aventis Us | ISUPREL | isoproterenol hydrochloride | SOLUTION;INHALATION | 006327-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Bausch | ISUPREL | isoproterenol hydrochloride | INJECTABLE;INJECTION | 010515-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Sanofi Aventis Us | ISUPREL | isoproterenol hydrochloride | SOLUTION;INHALATION | 006327-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
